NCT00251316View on ClinicalTrials.gov

Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Thyroid CancerDifferentiated Thyroid Carcinoma
Interventions
DRUG

Lithium Carbonate

30 mCi of 131I

DRUG

Placebo

Patients recently diagnosed with papillary or follicular thyroid cancer who have had their thyroid gland removed and whose cancer has not spread beyond the thyroid may be eligible for this study. Participants in this arm receive placebo (look-alike capsules with no active ingredient).

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00251316 - Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer | Biotech Hunter | Biotech Hunter